Hapnik

Hapnik is a prescription‑only medical gas that contains the active ingredient oxygen. It is supplied in an inhalation‑ready form for use in clinical settings across the EU. As a medical gas, Hapnik delivers oxygen to increase alveolar partial pressure, supporting tissue oxygenation in patients with respiratory or cardiac conditions.

Hapnik is indicated for patients who require supplemental oxygen to improve blood oxygen levels. It is commonly employed in acute and chronic respiratory care as well as emergency medicine.

- Treatment of hypoxemia caused by lung disease or high altitude - Management of respiratory distress in chronic obstructive pulmonary disease (COPD) - Support during cardiac arrest and resuscitation efforts - Peri‑operative oxygen supplementation to maintain adequate oxygenation - Palliative care to relieve dyspnea in terminal illnesses

Oxygen therapy with Hapnik can produce a range of expected and less common reactions. Most side effects are mild and related to the delivery system, while serious events are rare but require immediate attention.

Common: - Nasal or oral dryness - Mild headache - Irritation of the airway or throat - Coughing during inhalation - Temporary dizziness when adjusting flow rates

Serious: - Pulmonary oxygen toxicity (rare with prolonged high concentrations) - Fire hazard if oxygen leaks near ignition sources - Severe hypercapnia in patients with chronic CO2 retention - Acute lung injury from excessive pressure - Vision changes due to high oxygen exposure

Before prescribing Hapnik, clinicians should evaluate patient‑specific factors and environmental safety. Proper monitoring and equipment checks help minimize risks.

- Verify the patient’s baseline oxygen saturation and need for supplemental oxygen - Adjust flow rates to the lowest effective concentration to avoid toxicity - Use flame‑retardant equipment and keep away from open flames or sparks - Monitor for signs of carbon dioxide retention in COPD patients - Assess for contraindications such as untreated pneumothorax - Ensure proper storage at recommended temperature and pressure - Educate patients and caregivers on safe handling of the gas cylinder

Oxygen therapy can influence the effectiveness or safety profile of certain medications and medical conditions. Awareness of these interactions helps guide safe co‑administration.

Avoid: - Sodium nitrite, which can exacerbate methemoglobinemia when combined with high oxygen levels - Certain chemotherapeutic agents that increase oxidative stress - High‑concentration oxygen in patients receiving nitrous oxide anesthesia

Use with caution: - Sedatives and opioids that depress respiratory drive - Antioxidant supplements that may alter oxidative balance - Hyperbaric oxygen therapy protocols - Patients on chronic corticosteroid therapy - Individuals with severe anemia or polycythemia